V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002511 | 210008369 | 1.75 | 82 | Adjuvant (A) | null | 2018-06-07 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 101843454 |
| 210002513 | 210008370 | 1.65 | 55.1 | Curative (C) | 2018-05-01 | 2018-10-29 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101270981 |
| 210002514 | 210008371 | 1.69 | null | Adjuvant (A) | null | 2017-10-10 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100862573 |
| 210002515 | 210008372 | 1.63 | 61.85 | Adjuvant (A) | null | 2019-11-01 | Trastuzumab 21 day loading dose | 02 | N | TRASTUZUMAB | 100600748 |
| 210002520 | 210008373 | null | null | null | 2016-10-18 | 2017-04-17 | Trastuzumab | 02 | null | TRASTUZUMAB | 100491202 |
| 210002521 | 210008374 | null | 66.4 | Adjuvant (A) | null | 2018-11-23 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101405419 |
| 210002522 | 210008375 | 1.56 | 117 | Adjuvant (A) | 2019-01-05 | 2019-03-31 | CYCLOPHOSPHAMIDE + EPIRUBICIN | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101105884 |
| 210002523 | 210008376 | 1.5 | 50.9 | Adjuvant (A) | 2019-05-28 | 2019-06-10 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100711932 |
| 210002527 | 210008379 | null | null | Palliative (P) | 2021-05-25 | 2021-05-31 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100653585 |
| 210002528 | 210008380 | 1.58 | 58.1 | Adjuvant (A) | 2018-10-08 | 2019-02-06 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101433878 |
| 210002531 | 210008381 | 1.63 | 72.2 | Adjuvant (A) | null | 2018-01-07 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101501732 |
| 210002532 | 210008382 | 1.6 | 76 | Adjuvant (A) | null | 2018-04-25 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101630980 |
| 210002533 | 210008383 | 1.62 | 67.8 | null | 2018-11-13 | 2019-01-03 | Docetaxel | null | null | DOCETAXEL | 100734174 |
| 210002534 | 210008384 | 1.63 | 60.2 | Adjuvant (A) | null | 2016-07-18 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101568294 |
| 210002535 | 210008385 | 1.63 | 71.6 | Palliative (P) | 2020-05-24 | 2020-09-09 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101852999 |
| 210002537 | 210008387 | 1.6 | 90.5 | Neo-adjuvant (N) | null | 2019-07-19 | TRASTUZUMAB | null | null | TRASTUZUMAB | 100739547 |
| 210002538 | 210008388 | 1.61 | 55.3 | Palliative (P) | 2016-05-27 | 2016-08-18 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100234573 |
| 210002539 | 210008389 | 1.51 | 64 | Neo-adjuvant (N) | 2018-08-16 | 2018-11-05 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100210041 |
| 210002540 | 210008390 | 1.56 | 80.5 | Adjuvant (A) | 2016-01-27 | 2016-07-01 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100611363 |
| 210002542 | 210008391 | null | 62.8 | Neo-adjuvant (N) | 2019-01-16 | 2019-02-03 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100065216 |
| 210002543 | 210008392 | 1.69 | 70 | null | null | 2019-10-06 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101132495 |
| 210002545 | 210008393 | 1.54 | 64.1 | Palliative (P) | 2018-10-29 | 2019-04-21 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | PACLITAXEL | 100884492 |
| 210002546 | 210008394 | 1.67 | 74 | null | null | 2021-04-12 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100283532 |
| 210002550 | 210008395 | 1.64 | 76.3 | Adjuvant (A) | null | 2019-04-17 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100117369 |
| 210002551 | 210008396 | 1.76 | 48.9 | Adjuvant (A) | 2021-02-20 | 2021-08-31 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100423002 |
| 210002554 | 210008398 | 1.65 | 79.3 | Neo-adjuvant (N) | 2022-04-24 | 2022-05-11 | PACLITAXEL | null | N | PACLITAXEL | 101380221 |
| 210002555 | 210008399 | 1.61 | 56 | Adjuvant (A) | null | 2022-01-04 | Docetaxel | 02 | null | DOCETAXEL | 100509878 |
| 210002556 | 210008400 | 1.68 | null | Adjuvant (A) | null | 2018-11-06 | Trastuzumab | 02 | N | TRASTUZUMAB | 100056504 |
| 210002561 | 210008402 | 1.63 | null | Palliative (P) | null | 2018-03-27 | Docetaxel | 02 | N | DOCETAXEL | 100538153 |
| 210002563 | 210008403 | 1.55 | 65 | Adjuvant (A) | null | 2021-03-20 | PACLITAXEL | 02 | N | PACLITAXEL | 101302448 |
| 210002567 | 210008406 | 1.75 | 0 | null | 2017-03-04 | 2017-05-06 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101682300 |
| 210002568 | 210008407 | 1.75 | 76 | Adjuvant (A) | 2017-01-08 | 2017-03-20 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101560712 |
| 210002570 | 210008409 | 1.65 | 66.5 | null | null | 2017-10-26 | Trastuzumab Subcutaneous | null | null | TRASTUZUMAB | 100503940 |
| 210002571 | 210008410 | 1.69 | 50.4 | null | 2017-03-10 | 2017-05-23 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100023673 |
| 210002572 | 210008411 | 1.61 | 66.1 | Adjuvant (A) | null | 2018-11-02 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101158041 |
| 210002576 | 210008413 | 1.61 | 55.3 | Adjuvant (A) | 2017-11-22 | 2017-12-01 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100815437 |
| 210002578 | 210008414 | 1.55 | 56 | Adjuvant (A) | 2018-12-01 | 2018-12-07 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100134272 |
| 210002579 | 210008415 | null | 70.5 | null | 2019-05-25 | 2019-06-07 | Trastuzumab | 02 | null | TRASTUZUMAB | 101193499 |
| 210002580 | 210008416 | null | 81 | null | 2018-04-28 | 2018-07-12 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 100860263 |
| 210002581 | 210008417 | 1.65 | 87 | Adjuvant (A) | 2019-05-03 | 2019-05-06 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | PACLITAXEL | 101665933 |
| 210002582 | 210008418 | 1.75 | 59.8 | null | null | 2021-05-20 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100693101 |
| 210002583 | 210008419 | 1.88 | 78 | null | null | 2016-09-29 | Paclitaxel (2 or 3 weekly) | 02 | N | PACLITAXEL | 100273667 |
| 210002584 | 210008420 | 1.69 | 70.9 | Neo-adjuvant (N) | null | 2016-05-16 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100119633 |
| 210002585 | 210008421 | 1.6 | 81.6 | Adjuvant (A) | 2018-06-17 | 2019-11-05 | Paclitaxel 7 day | 02 | Y | PACLITAXEL | 100680230 |
| 210002590 | 210008424 | 1.75 | 58 | null | 2019-07-31 | 2019-08-12 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101244281 |
| 210002591 | 210008425 | 1.63 | 67 | null | 2016-06-08 | 2016-10-02 | PACLITAXEL | null | null | PACLITAXEL | 100810001 |
| 210002594 | 210008427 | 1.59 | 65.3 | Adjuvant (A) | 2017-08-19 | 2017-10-21 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101692606 |
| 210002595 | 210008428 | 1.48 | 114.8 | Neo-adjuvant (N) | 2020-09-06 | 2020-10-12 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101662878 |
| 210002596 | 210008429 | 1.51 | 103 | Adjuvant (A) | 2019-01-27 | 2019-02-26 | Trastuzumab 21 day loading dose | 02 | N | TRASTUZUMAB | 101122396 |
| 210002597 | 210008430 | 1.69 | 82.9 | Adjuvant (A) | 2018-12-20 | 2019-02-01 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100883491 |